Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 16,485 | 13,129 | 12,605 | 13,890 | 13,937 |
| Cost of Goods | 1,311 | 824 | 671 | 819 | 484 |
| Gross Profit | 15,174 | 12,305 | 11,934 | 13,071 | 13,453 |
| Operating Expenses | 18,880 | 14,058 | 16,236 | 15,397 | 16,405 |
| Operating Income | -3,706 | -1,753 | -4,302 | -2,326 | -2,952 |
| Interest Expense | 1,831 | 1,428 | 1,527 | 1,521 | 1,611 |
| Other Income | -1,184 | 1,700 | -1,343 | 2,922 | -8,213 |
| Pre-tax Income | -6,721 | -1,481 | -7,172 | -925 | -12,776 |
| Income Tax | 557 | 252 | -698 | -1,079 | -556 |
| Net Income Continuous | -7,278 | -1,733 | -6,474 | 154 | -12,220 |
| Net Income | $-7,278 | $-1,733 | $-6,474 | $154 | $-12,220 |
| EPS Basic Total Ops | -0.23 | -0.05 | -0.20 | 0.00 | -0.42 |
| EPS Basic Continuous Ops | -0.23 | -0.05 | -0.20 | 0.00 | -0.42 |
| EPS Diluted Total Ops | -0.23 | -0.05 | -0.20 | 0.00 | -0.42 |
| EPS Diluted Continuous Ops | -0.23 | -0.05 | -0.20 | 0.00 | -0.42 |
| EBITDA(a) | $4,623 | $6,863 | $2,553 | $9,155 | $-3,011 |